Compare GE Vernova Inc (GEV) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE Vernova Inc vs Teladoc Health Inc — how do they compare? GE Vernova Inc trades at $1,043.83 (market cap $283.57B), while Teladoc Health Inc trades at $9.72 (market cap $1.75B). The key difference: GE Vernova Inc is far larger — about 162× Teladoc Health Inc's market cap, and GE Vernova Inc pays a 0.19% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals.
| GEV | TDOC | |
|---|---|---|
Market Cap | $283.57B | $1.75B |
Sector | Technology | Health |
52-Week High | $1.17K | $9.72 |
52-Week Low | $547.96 | $4.47 |
Enterprise Value | $276.21B | $2.04B |
Dividend Yield | 0.19% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE Vernova (GEV) trades at $1,038, down 2.63% today, with mixed technical signals showing bearish overall momentum but bullish moving averages. The company demonstrates strong profitability with 23.81% net income margin and 83.23% ROE, though valuation metrics appear elevated with P/E of 30.84 and EV/EBITDA of 109.82. Recent earnings showed volatility with Q1 2026 beating expectations by a wide margin, while the company prepares for Q2 2026 results amid significant AI-driven power demand growth.
The outlook remains positive with analyst consensus strongly bullish (21 buy ratings, 0 sell) and $1,260 price target representing 21% upside. Key opportunities include AI data center power demand and $11 billion investment push, while risks include wind segment pressures and elevated valuation multiples that may limit near-term upside potential despite strong fundamentals.
TDOC trades at $9.27, down 3.94% on the day, with a bullish technical signal from moving averages. The company reported revenue of $2.53B in 2025 but posted a net loss of $200.32M. Recent news highlights the Walmart partnership expansion and upcoming Q2 2026 earnings. Analyst consensus is mixed with 35.71% buy ratings but a price target below current levels at $8.75.
The outlook remains cautious due to persistent losses despite revenue stability. Investment opportunity exists if cost controls and partnerships drive profitability. Key risks include competitive pressures, weak BetterHelp segment, and negative cash flow trends. The stock faces headwinds until sustainable earnings improvement is demonstrated.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GE Vernova Inc
GE Vernova is a global leader in the electric power industry. It provides sustainable energy solutions across gas, wind, and hydro sectors, focusing on modernizing the world's power grids.
Read more on GEV →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
